Viral Gene Therapy

The potential usefulness of viral gene replacement therapy in human disease has been an exciting and extensively-studied topic in the field of skeletal muscle disease for the past 20 years. Unfortunately, while the strategy of replacing or supplementing copies of mutant gene is a straightforward concept, a number of complicating factors have been identified as gene therapy trials have progressed toward clinical studies. While some of these issues, including the immunological response to viral vectors, are issues that are encountered with all forms of gene therapy, the use of gene therapy in skeletal muscle also poses additional challenges for which treatment strategies need to be optimized. Despite these challenges, there has been substantial progress in recent years toward optimizing viral gene therapy for skeletal muscle disease in animal models, with an eye toward optimizing the safety and efficacy of viral gene therapy in humans. Skeletal muscle disorders represent considerable opportunities for investigators developing viral gene therapy strategies, due to the numerous monogenetic diseases of skeletal muscle, the clear and quantifiable clinical phenotypes, and the easy accessibility of muscle tissue. Mutations in the dystrophin gene predispose the myofiber membrane to contraction-induced membrane damage, resulting in inflammation, and myonecrosis, and progressive loss of functional muscle tissue. Several murine and canine models of dystrophinopathy have been used to study these diseases and evaluate potential therapies, including several viral gene therapy approaches. Viral gene therapy approaches have also been investigated for other disorders of skeletal muscle, including lysosomal storage disorders and congenital myopathies, and these studies have benefitted immensely from the pioneering work that was performed using dystrophinopathy models.

    Related Conference of Viral Gene Therapy

    June 09-10, 2020

    4th International Conference on Medical & Clinical Microbiology

    Singapore City, Singapore
    June 15-16, 2020

    49th World Congress on Microbiology

    London, UK
    June 15-16, 2020

    Cell Tissue Science 2020

    Valencia, Spain
    June 24-25, 2020

    12th International Virology Summit

    Rome, Italy
    June 26-26, 2020

    Clinical Microbiology and Infectious Diseases

    Paris, France
    June 26-26, 2020

    Webinar on Applied Microbiology and Biotechnology

    Paris, France
    July 27-28, 2020

    28th World Summit on Genetics and Genomics

    Madrid, Spain
    August 26-27, 2020

    13thAnnual Meet on Bacteriology & Applied Microbiology

    Singapore City, Singapore
    September 02-03, 2020

    5th International Conference on Bacteriology

    Barcelona, Spain
    September 17-18, 2020

    3rd World Congress on Virology and Diseases Control

    Vienna, Austria
    September 18-19, 2020

    2nd International Conference on Cell Metabolism

    Dubai, UAE
    September 21-22, 2020

    12th Global Summit on Immunology and Cell Biology

    Valencia, Spain
    September 25-26, 2020

    Annual Congress on Clinical Microbiology and Yeast Congress

    Vancouver, Canada
    September 28-29, 2020

    8th World Congress and Expo on Applied Microbiology

    Barcelona, Spain
    November 11-12, 2020

    International Conference on Applied Microbiology

    Tokyo, Japan
    November 11-12, 2020

    International Conference on Microbiology

    Tokyo, Japan
    November 25-26, 2020

    5th World Conference on Applied Microbiology and Beneficial Microbes

    Singapore City, Singapore
    December 03-04, 2020

    3rd World Pediatric Infectious Disease Congress

    Singapore City, Singapore
    December 07-08, 2020

    International Conference on Molecular Microbiology

    Dubai, UAE
    December 07-08, 2020

    3rd World Congress on Microbiology and Clinical research

    Singapore City, Singapore

    Viral Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in